Trial Profile
A pilot study of Pemetrexed, Platinum agent plus Bevacizumab for advanced non-squamous non-small cell lung cancer with brain metastases
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 Mar 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Pemetrexed (Primary) ; Carboplatin; Cisplatin
- Indications Brain metastases; Non-small cell lung cancer
- Focus Therapeutic Use
- 05 Mar 2015 According to the University Hospital Medical Information Network - Japan record, status changed from recruiting to discontinued.
- 03 Sep 2013 New trial record